Press release
PreDiabetes Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharma
"PreDiabetes Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the PreDiabetes Market.
The PreDiabetes Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the PreDiabetes Pipeline Report:
https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel PreDiabetes treatment therapies with a considerable amount of success over the years.
• PreDiabetes companies working in the treatment market are NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharmaceutical Group Co., Ltd., Valbiotis, Resverlogix, Boston Therapeutics, and others, are developing therapies for the PreDiabetes treatment
• Emerging PreDiabetes therapies in the different phases of clinical trials are- OKV-119, Anaerostipes rhamnosivorans, Intestinimonas, INV-202, HSK7653, Eubacterium Hallii, Totum-63, Apabetalone, BTI-320, and others are expected to have a significant impact on the PreDiabetes market in the coming years.
PreDiabetes Overview
Pre-diabetes is a condition characterized by blood glucose levels that are higher than normal but not yet high enough to be diagnosed as type 2 diabetes. It's considered an intermediate stage between normal glucose levels and diabetes. Individuals with pre-diabetes are at increased risk of developing type 2 diabetes, heart disease, and stroke. However, pre-diabetes can often be reversed through lifestyle changes such as weight loss, healthy eating, and increased physical activity. Regular monitoring and early intervention can help prevent or delay the onset of type 2 diabetes in individuals with pre-diabetes.
Get a Free Sample PDF Report to know more about PreDiabetes Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging PreDiabetes Drugs Under Different Phases of Clinical Development Include:
• OKV-119: NanoPrecision Medical
• Anaerostipes rhamnosivorans: Caelus Health
• Intestinimonas: Caelus Health
• INV-202: Inversago Pharma Inc.
• HSK7653: Haisco Pharmaceutical Group Co., Ltd.
• Eubacterium Hallii: Caelus Health
• Totum-63: Valbiotis
PreDiabetes Route of Administration
PreDiabetes pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Intravenous
• Subcutaneous
PreDiabetes Molecule Type
PreDiabetes Products have been categorized under various Molecule types, such as
• Small molecule
• Cell Therapy
• Peptides
• Polymer
• Small molecule
• Gene therapy
PreDiabetes Pipeline Therapeutics Assessment
• PreDiabetes Assessment by Product Type
• PreDiabetes By Stage and Product Type
• PreDiabetes Assessment by Route of Administration
• PreDiabetes By Stage and Route of Administration
• PreDiabetes Assessment by Molecule Type
• PreDiabetes by Stage and Molecule Type
DelveInsight's PreDiabetes Report covers around 15+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further PreDiabetes product details are provided in the report. Download the PreDiabetes pipeline report to learn more about the emerging PreDiabetes therapies
https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the PreDiabetes Therapeutics Market include:
Key companies developing therapies for PreDiabetes are - Resverlogix Corporation, Boston Therapeutics, vTv Therapeutics, Valbiotis, BioTeSys, SynDevRx, Caelus Health, NanoPrecision Medical, and others.
PreDiabetes Pipeline Analysis:
The PreDiabetes pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of PreDiabetes with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for PreDiabetes Treatment.
• PreDiabetes key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• PreDiabetes Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the PreDiabetes market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about PreDiabetes drugs and therapies
https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
PreDiabetes Pipeline Market Drivers
• Increase in prevalence of prediabetes, increase in Diagnosis and Growing investments in research and development are some of the important factors that are fueling the PreDiabetes Market.
PreDiabetes Pipeline Market Barriers
• However, side effects associated with Drugs, lack of Awareness among Patients and other factors are creating obstacles in the PreDiabetes Market growth.
Scope of PreDiabetes Pipeline Drug Insight
• Coverage: Global
• Key PreDiabetes Companies: NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharmaceutical Group Co., Ltd., Valbiotis, Resverlogix, Boston Therapeutics, and others
• Key PreDiabetes Therapies: OKV-119, Anaerostipes rhamnosivorans, Intestinimonas, INV-202, HSK7653, Eubacterium Hallii, Totum-63, Apabetalone, BTI-320, and others
• PreDiabetes Therapeutic Assessment: PreDiabetes current marketed and PreDiabetes emerging therapies
• PreDiabetes Market Dynamics: PreDiabetes market drivers and PreDiabetes market barriers
Request for Sample PDF Report for PreDiabetes Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. PreDiabetes Report Introduction
2. PreDiabetes Executive Summary
3. PreDiabetes Overview
4. PreDiabetes- Analytical Perspective In-depth Commercial Assessment
5. PreDiabetes Pipeline Therapeutics
6. PreDiabetes Late Stage Products (Phase II/III)
7. PreDiabetes Mid Stage Products (Phase II)
8. PreDiabetes Early Stage Products (Phase I)
9. PreDiabetes Preclinical Stage Products
10. PreDiabetes Therapeutics Assessment
11. PreDiabetes Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. PreDiabetes Key Companies
14. PreDiabetes Key Products
15. PreDiabetes Unmet Needs
16 . PreDiabetes Market Drivers and Barriers
17. PreDiabetes Future Perspectives and Conclusion
18. PreDiabetes Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
PreDiabetes Market
https://www.delveinsight.com/report-store/prediabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'PreDiabetes Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
PreDiabetes Epidemiology
https://www.delveinsight.com/report-store/prediabetes-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'PreDiabetes Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports Offered By DelveInsight:
Iga Nephropathy Market
https://www.delveinsight.com/report-store/iga-nephropathy-market
DelveInsight's "IgA Nephropathy Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of the IgA Nephropathy, historical and forecasted epidemiology as well as the IgA Nephropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, Japan, and China.
Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market
DelveInsight's "Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Vutrisiran, historical and forecasted epidemiology as well as the Vutrisiran market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Gastroesophageal Reflux Disease Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
DelveInsight's "Gastroesophageal Reflux Disease (GERD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastroesophageal Reflux Disease (GERD), historical and forecasted epidemiology as well as the Gastroesophageal Reflux Disease (GERD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
DelveInsight's 'Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2032' report delivers an in-depth understanding of cerebral palsy, historical and forecasted epidemiology as well as cerebral palsy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
DelveInsight's "Hemophilia A Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hemophilia A, historical and forecasted epidemiology as well as the Hemophilia A market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Graft Versus Host Disease Market https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
DelveInsight's "Graft Versus Host Disease (GvHD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Graft Versus Host Disease, historical and forecasted epidemiology as well as the Graft Versus Host Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
DelveInsight's "Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
DelveInsight's "Asthma - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.
Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
DelveInsight's "Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myelodysplastic Syndrome, historical and forecasted epidemiology as well as the Myelodysplastic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PreDiabetes Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharma here
News-ID: 3460714 • Views: …
More Releases from DelveInsight Business Research
Autistic Disorder Pipeline 2025: In-depth Clinical Trials Analysis and Emerging …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Autistic Disorder pipeline constitutes 25+ key companies continuously working towards developing 25+ Autistic Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Autistic Disorder Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also…
Hypovolemic Shock Market Growth to Accelerate in Forecast Period (2024-2032), De …
The Hypovolemic Shock market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hypovolemic Shock pipeline products will significantly revolutionize the Hypovolemic Shock market dynamics.
DelveInsight's "Hypovolemic Shock Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Hypovolemic Shock, historical and forecasted epidemiology as well as the Hypovolemic Shock market trends in the United…
Chronic Insomnia Market to Expand Significantly by 2034, States DelveInsight Rep …
The Chronic Insomnia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics.
DelveInsight's "Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Insomnia, historical and forecasted epidemiology as well as the Chronic Insomnia market trends in the United States,…
Chronic Spontaneous Urticaria Market Growth Projections 2024-2034: DelveInsight …
DelveInsight's "Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Spontaneous Urticaria, historical and forecasted epidemiology as well as the Chronic Spontaneous Urticaria market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Chronic Spontaneous Urticaria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Spontaneous Urticaria…
More Releases for PreDiabetes
Prediabetes Market is expected to reach USD 43.9 billion by 2034
Prediabetes is a high-risk health condition where blood glucose levels are elevated above normal but not high enough for a type 2 diabetes diagnosis. According to global health estimates, over 480 million adults were living with prediabetes in 2024, and this number is expected to increase substantially by 2034 due to sedentary lifestyles, obesity, poor dietary patterns, and genetic susceptibility.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72063
If unmanaged,…
Prediabetes Market Rising Demand and Growth Forecast Through 2033
The Global Prediabetes Market was valued at approximately USD 201.65 million in 2023 and is projected to reach around USD 405.66 million by 2033, representing a compound annual growth rate (CAGR) of about 7.24% from 2024 to 2033.
Prediabetes Market Overview
The prediabetes market is gaining momentum as increasing global rates of obesity, sedentary lifestyles, and metabolic risk factors drive the need for early diagnosis and intervention. Market growth is fueled by…
Prediabetes Market Comprehensive Research Study, Business Overview and Regional …
The global Prediabetes Market is estimated to be valued at approximately USD 3.6 billion in 2024, and it is projected to reach around USD 7.8 billion by 2033, growing at a CAGR of 8.7% during the forecast period from 2025 to 2033.
Prediabetes Market Overview
The Prediabetes Market is witnessing substantial growth due to the rising prevalence of prediabetes and type 2 diabetes worldwide. Increasing awareness about early diagnosis and preventive…
Prediabetes Market Development, Industry Trends, Demand and Growth Analysis and …
The global Prediabetes Market was valued at approximately USD 14.5 billion in 2024 and is projected to reach around USD 32.8 billion by 2033, growing at a CAGR of 9.4% from 2025 to 2033.
Prediabetes Market Overview:
The prediabetes market is witnessing significant growth due to the rising global prevalence of sedentary lifestyles, unhealthy dietary patterns, and increasing obesity rates. Growing awareness regarding early diagnosis and preventive healthcare is fueling demand for…
Prediabetes Market: Advancing Early Interventions for Metabolic Health
𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐫𝐞𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐭 𝐭𝐨 𝐑𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟓𝟗𝟗.𝟑𝟒 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟑, 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟕.𝟏𝟓%
The prediabetes market is experiencing significant growth as the world faces an increasing burden of metabolic disorders. Valued at USD 322.14 million in 2024, the market is projected to expand to USD 599.34 million by 2033, reflecting a CAGR of 7.15%.
𝐓𝐡𝐞 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐬𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: - https://www.astuteanalytica.com/request-sample/prediabetes-market
With 470 million individuals globally diagnosed with…
Prediabetes Market Size Forecast Between 2023-2032
Prediabetes, a condition characterized by higher than normal blood sugar levels, is a precursor to type 2 diabetes. With the rising prevalence of obesity, sedentary lifestyles, and unhealthy dietary habits, the prediabetes market is witnessing significant growth globally. This article delves into the competitive landscape, future growth prospects, opportunities, drivers, and restraints within the prediabetes market, offering insights into key market players, current trends, and regional dynamics.
Download Free Prediabetes Market…
